MRNS - MARINUS PHARMACEUTICALS, INC.

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 1.385

Open

$ 1.51

Bid

$ 1.38 x 100

Ask

$ 1.39 x 1,600

Day's Range

$ 1.38 - $ 1.51

52 Week Range

$ 1.11 - $ 11.26

Volume

1,221,211

Average Volume

Market Cap

78.74M

Beta (5Y Monthly)

$ 0.81

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	03-05-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-09-2023	12-31-2022	10-K
7	11-07-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-24-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	08-10-2021	06-30-2021	10-Q
13	05-17-2021	03-31-2021	10-Q
14	03-09-2021	12-31-2020	10-K
15	11-09-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-04-2020	03-31-2020	10-Q
18	03-16-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-01-2019	03-31-2019	10-Q
22	03-12-2019	12-31-2018	10-K
23	10-29-2018	09-30-2018	10-Q
24	08-03-2018	06-30-2018	10-Q
25	05-02-2018	03-31-2018	10-Q
26	03-07-2018	12-31-2017	10-K
27	10-31-2017	09-30-2017	10-Q
28	08-01-2017	06-30-2017	10-Q
29	05-01-2017	03-31-2017	10-Q
30	03-13-2017	12-31-2016	10-K
31	11-08-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	05-02-2016	03-31-2016	10-Q
34	03-07-2016	12-31-2015	10-K
35	10-29-2015	09-30-2015	10-Q
36	08-04-2015	06-30-2015	10-Q
37	05-14-2015	03-31-2015	10-Q
38	03-12-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q
40	09-12-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Mari...
05/09/2024 10:47:55

HC Wainwright & Co. analyst Douglas Tsao reiterates Marinus Pharma (NASDAQ:MRNS) with a Buy and maintains $11 price target.

Marinus Pharmaceuticals Expects That Cash,...
05/08/2024 11:11:22

Marinus Pharmaceuticals Has Increased 2024...
05/08/2024 11:10:26

Marinus Pharma Q1 2024 GAAP EPS $(0.68) Mi...
05/08/2024 11:08:23

Marinus Pharma (NASDAQ:MRNS) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0....

Unveiling 10 Analyst Insights On Marinus P...
05/07/2024 16:00:57

HC Wainwright & Co. Maintains Buy on Marin...
05/07/2024 14:00:08

HC Wainwright & Co. analyst Douglas Tsao maintains Marinus Pharma (NASDAQ:MRNS) with a Buy and lowers the price target f...

how-is-the-market-feeling-about-marinus-pharma

How Is The Market Feeling About Marinus Ph...
04/29/2024 14:45:15

Visa To Rally Around 18%? Here Are 10 Top ...
04/17/2024 12:21:44

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

RBC Capital Downgrades Marinus Pharma to S...
04/17/2024 09:39:47

RBC Capital analyst Brian Abrahams downgrades Marinus Pharma (NASDAQ:MRNS) from Outperform to Sector Perform and lowers the ...

analysts-question-commercial-viability-of-marinus-iv-ganaxolone-after-interim-analysis-miss

Analysts Question Commercial Viability of ...
04/16/2024 18:45:12

Marinus Pharmaceuticals' phase 3 RAISE trial on IV ganaxolone for refractory status epilepticus fails interim analysis. Fut...

The Latest Analyst Ratings For Marinus Pharma
04/16/2024 17:00:23

HC Wainwright & Co. Reiterates Buy on Mari...
04/16/2024 14:59:23

HC Wainwright & Co. analyst Douglas Tsao reiterates Marinus Pharma (NASDAQ:MRNS) with a Buy and maintains $27 price target.

RBC Capital Downgrades Marinus Pharma to S...
04/15/2024 18:52:23

RBC Capital analyst Brian Abrahams downgrades Marinus Pharma (NASDAQ:MRNS) from Outperform to Sector Perform and lowers the ...

sp-500-down-over-1-us-retail-sales-increase-07-in-march

S&P 500 Down Over 1%; US Retail Sales Incr...
04/15/2024 18:30:37

U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0...

why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ultragenyx Pharmaceutical Shares Are T...
04/15/2024 18:11:35

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/15/2024 16:31:47

Crude Oil Down 1%; Charles Schwab Sales To...
04/15/2024 16:02:33

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow tra...

why-did-epilepsyseizure-focused-marinus-pharmaceuticals-stock-hit-52-week-low-on-monday

Why Did Epilepsy/Seizure Focused-Marinus P...
04/15/2024 14:13:07

Marinus Pharmaceuticals provides updates on Phase 3 RAISE trial for refractory status epilepticus treatment with IV ganaxolone....

dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings

Dow Jumps Over 300 Points; Goldman Sachs P...
04/15/2024 14:00:00

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.8...

marinus-pharmaceuticals-neumora-therapeutics-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Marinus Pharmaceuticals, Neumora Therapeut...
04/15/2024 12:19:30

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.